T. Rowe Price Associates’s Omega Protein OME Stock Holding History

T. Rowe Price Associates’s Portfolio OME Stock Details OME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-16,280	Closed	-$271K	–	2659
2017 Q3	$271K	Hold	16,280	–	–	﹤0.01%	2314
2017 Q2	$291K	Hold	16,280	–	–	﹤0.01%	2253
2017 Q1	$326K	Buy	16,280 +430	+3%	+$10K	﹤0.01%	2220
2016 Q4	$397K	Buy	15,850 +3,230	+26%	+$76.3K	﹤0.01%	2147
2016 Q3	$295K	Sell	12,620 -5,640	-31%	-$133K	﹤0.01%	2222
2016 Q2	$365K	Buy	18,260 +3,900	+27%	+$72.8K	﹤0.01%	2091
2016 Q1	$243K	Buy	+14,360	New	+$294K	﹤0.01%	2238

T. Rowe Price Associates's OME Position: Q4 2017 in Review

T. Rowe Price Associates sold out of Omega Protein (OME) in Q4 2017, closing a stake of 16,280 shares — an estimated $271K sold.

T. Rowe Price Associates first reported a position in OME in Q1 2016 and held it in 7 quarters. The position peaked at $397K in Q4 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.

T. Rowe Price Associates reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
T. Rowe Price Associates sold 16,280 Omega Protein shares in Q4 2017, an estimated $271K.
T. Rowe Price Associates first reported a position in Omega Protein in Q1 2016 and held it in 7 quarters.
T. Rowe Price Associates's Omega Protein position peaked at $397K in Q4 2016.
0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.

Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.